Clinical Safety of Gadoteridol, Representative of the Macrocyclic Class of Gadolinium-Based Contrast Agents.

Runge, Val Murray (2020). Clinical Safety of Gadoteridol, Representative of the Macrocyclic Class of Gadolinium-Based Contrast Agents. Journal of magnetic resonance imaging, 51(3), pp. 869-870. Wiley Interscience 10.1002/jmri.26957

[img] Text
Runge-2019-Journal_of_Magnetic_Resonance_Imaging.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (66kB)

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Institute of Diagnostic, Interventional and Paediatric Radiology

UniBE Contributor:

Runge, Val Murray

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1053-1807

Publisher:

Wiley Interscience

Language:

English

Submitter:

Maria de Fatima Henriques Bernardo

Date Deposited:

21 Oct 2019 13:15

Last Modified:

05 Dec 2022 15:31

Publisher DOI:

10.1002/jmri.26957

PubMed ID:

31614049

BORIS DOI:

10.7892/boris.134020

URI:

https://boris.unibe.ch/id/eprint/134020

Actions (login required)

Edit item Edit item
Provide Feedback